Casey McPherson: Why 95% of Rare Genetic Diseases Have Zero FDA-Approved Treatments, and What AlphaRose Is Doing About It
There is a medicine access problem emerging for millions of patients. More than 10,000 rare diseases have been…
Browsing Category
Executive leadership, reimagined.
Discover how experienced leaders deliver high-impact guidance without a full-time footprint. This section explores the rise of fractional executives—offering strategic depth, flexibility, and speed for organizations navigating growth, transition, or transformation.